A promising new treatment shows effectiveness in treating blood cancer, boosting the immune system, and potentially even tackling highly aggressive brain tumors
A woman’s brain tumor showed significant shrinkage after receiving a recently reported treatment. This has sparked interest in its potential for treating aggressive tumors.
A 57-year-old woman reportedly experienced significant cancer regression following CAR-T therapy, according to The Sun on March 14. CAR-T therapy is a treatment that aims to strengthen the immune system to fight cancer cells.
The woman participated in a clinical trial between March and July last year involving three glioblastoma patients undergoing CAR-T therapy.
All three patients reportedly saw tremendous effects through this treatment.
Dr. Elizabeth Gerstner of Massachusetts General Hospital shared, “We saw a dramatic and rapid response from these three patients. The research shows positive promise, but further work is needed.”
Glioblastoma, a highly aggressive brain tumor, affects about 3,200 Britons each year.
Several celebrities, including Tom Parker, Annabel Giles, Laura Nuttall, and former British Labour Party politician Dame Tessa Jowell, have died from this disease.
Current cancer treatments often involve surgery, radiotherapy, and chemotherapy. A recent study published in the prestigious New England Journal of Medicine explored the potential of CAR-T therapy as a promising alternative.
CAR-T therapy has been shown to cure specific blood cancers and trains the body’s immune system to recognize and attack cancer cells.
Besides the woman who experienced a significant tumor reduction following CAR-T therapy, the two other patients in the study also showed positive responses. One 72-year-old man reportedly saw his tumor size decrease by about 18% within two days of the treatment.
While acknowledging the groundbreaking nature of CAR-T therapy, several researchers highlighted the challenges in applying it to solid tumors like glioblastoma, as individual cancer cells within the tumor can have different characteristics.
“Our ultimate goal is a complete cure,” They shared. “This patient’s response is a promising initial finding that validates our research approach.”
Most Commented